NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

NCT01471834

Active Not RecruitingNA

Sponsor: CVRx, Inc.

Conditions: High Blood Pressure

Interventions: BAROSTIM NEO System, Medical Management

Countries: Canada, Germany, Netherlands

To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.

Eligibility overview

Sex: ALL

Age: 21 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Actively participating in the Neo Non-Randomized Hypertension Study.
* Have signed a revised approved informed consent form for continued participation in this study.

Exclusion Criteria:

* Treating physician decision that the subject should not continue with therapy.

Locations (9)

Calgary, Alberta, Canada
Edmonton, Alberta, Canada
London, Ontario, Canada
Cologn, Germany
Düsseldorf, Germany
Göttingen, Germany
Hanover, Germany
Leipzig, Germany
Maastricht, Netherlands